Wave Life Sciences WVE Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's deferred revenue?
- Wave Life Sciences (WVE) reported deferred revenue of $9.4M in Q1 2026.
- How has Wave Life Sciences's deferred revenue changed year-over-year?
- Wave Life Sciences's deferred revenue decreased by 83.6% year-over-year, from $57.31M to $9.4M.
- What is the long-term trend for Wave Life Sciences's deferred revenue?
- Over 5 years (2020 to 2025), Wave Life Sciences's deferred revenue has grown at a -13.5% compound annual growth rate (CAGR), from $91.56M to $44.44M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.